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INTRODUCTION
Leishmaniasis has been identified as a major public
health problem in tropical and sub-tropical areas, where
the infection is transmitted by the bite of a female sandfly.
It is endemic in 98 countries and territories, affecting 12
million people and approximately threatens 350 million
people around the world1. Cutaneous leishmaniasis (CL)
is the most common type of leishmaniasis affecting 1.5
million people annually, worldwide. About 90% of the
cases are reported from countries such as Iran, Afghani-
stan, Pakistan, Iraq, Saudi Arabia, Syria and Peru2–3.
Due to the non-avaialability of potential effective
vaccine, drug treatment is the the only control option
against leishmaniasis4–5. The first choice treatment of CL
is pentavalent antimony compounds including meglumine
antimoniate (MA) and sodium stibogluconate (SSG),
which are widely prescribed despite their toxicity, high
cost, difficulty in administration and emergence of resis-
tant parasites6–8. These factors emphasize the urgent need
for development of new effective treatment alternatives.
Natural products are valuable sources commonly used
as alternative medicines to treat a wide range of diseases
such as infectious diseases9. European barberry, Berbesis
vulgaris L. (Berberidaceae), grows in Asia and Europe.
B. vulgaris called “Zereshk” in Persian is native to south-
east of Iran. Previously, various studies have been car-
ried out on chemical composition of B. vulgaris which
indicated that the most important constituents of this plant
are isoquinoline alkaloids such as berbamine, palmatine
and particularly berberine10. Different parts of this plant
including root, leaf, bark and fruit have widely been used
as folk medicine for the preventation and treatment of
various diseases including cardiovascular, gastrointesti-
nal, respiratory, skin, renal and infectious diseases10. Fur-
thermore, antibacterial, antifungal and antiparasitic effects
of B. vulgaris and its derived compounds against some
pathogenic strains have also been shown10–12.
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ABSTRACT
Background & objectives: Leishmaniasis is a major public health problem, and the alarming spread of parasite
resistance underlines the importance of discovering new therapeutic products. The present study aims to investigate
the in vitro antileishmanial activity and cytotoxicity of the ethanolic extract of Berberis vulgaris fruits and
chloroform extract of Nigella sativa seeds against Leishmania tropica.
Methods: In this study, antileishmanial activity of B. vulgaris and N. sativa extracts on promastigote and amastigote
stages of L. tropica in comparison to meglumine antimoniate (MA) was evaluated, using MTT assay and macrophage
model, respectively. MTT test was also used to assess the cytotoxicity of extracts on murine macrophages. The
significance of differences was determined by analysis of variances (ANOVA) and student’s t-test using SPSS
software.
Results: The results showed that ethanolic extract of B. vulgaris (IC50 4.83 μg/ml) and chloroform extract of N.
sativa (IC50 7.83 μg/ml) significantly reduced the viability of promastigotes of L. tropica in comparison to MA
(IC50 11.26 μg/ml). Furthermore, extracts of B. vulgaris (IC50 24.03 μg/ml) and N. sativa (IC50 30.21 μg/ml)
significantly decreased the growth rate of amastigotes in each macrophage as compared with positive control
(p <0.05). Our findings also revealed that extracts of B. vulgaris and N. sativa had no significant cytotoxicity
against murine macrophages.
Conclusion: The B. vulgaris and N. sativa extracts exhibited an effective leishmanicidal activity against L. tropica
on in vitro model. Further, works are required to evaluate the exact effect of these extracts on Leishmania species
using a clinical setting.
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Nigella sativa L. commonly known as black seed from
Ranunculaceae family grows in the southern Europe,
North Africa, Middle East and Western Asia. Nigella sa-
tiva called “Siah Daneh” in Persian has long been tradi-
tionally used as a natural medicine for treatment of many
acute as well as chronic conditions including hyperten-
sion, diabetes, cough, bronchitis, headache, eczema, fe-
ver and dizziness13. Reviews have reported that N. sativa
has antioxidant and neuroprotective effects in addition to
many other therapeutic activities such as antitumor,
immunopotentiation, anti-inflammatory, antiasthmatic
and antimicrobial properties14. Moreover, studies have
revealed antibacterial, antifungal, antiviral and antipara-
sitic effects of N. sativa and its derivatives13–15.
This study was aimed to evaluate the antileishmanial
effects of ethanolic extract of B. vulgaris fruits and chlo-
roform extract of N. sativa seeds against promastigote
and amastigote stages of L. tropica using colorimetric
assay [3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyl tetrazo-
lium bromide)]—MTT and macrophage model, respec-
tively. In addition, in this survey, the inhibition of infec-
tion in macrophages (infectivity rate) and cytotoxicity




Meglumine antimoniate (MA, Glucantime) as con-
trol drug was purchased from Rhône, Poulenc, France and
penicillin and streptomycin were procured from Alborz
Pharmacy, Karaj, Iran and were stored at room tempera-
ture (25°C) until testing. MTT powder [3-(4.5-
dimethylthiazol-2-yl)-2.5-diphenyl tetrazolium bromide)],
fetal calf serum (FCS) and RPMI-1640 medium with L-
glutamine were purchased from Sigma-Aldrich, St Louis,
MA (USA). All other chemicals and solvents were of ana-
lytical grade.
Parasite and cell culture
Leishmania tropica standard strain (MHOM/IR/2002/
Mash2) was kindly prepared by the Center for Research
and Training in Skin Diseases and Leprosy, Tehran, Iran.
The parasite was cultured in NNN medium, sub-cultured
in RPMI-1640, supplemented with penicillin (200 IU/ml),
streptomycin (100 μg/ml), and 15% heat-inactivated FCS.
Murine macrophages were collected from male BALB/c
mice (4–8 wk old) by injecting 2–5 ml of cold RPMI-
1640 medium into mouse peritoneal cavity and then as-
pirated macrophages were washed twice and re-suspended
in RPMI-1640 medium. The experimental procedures
carried out in this survey were in compliance with the
guidelines of the Kerman University of Medical Sciences,
Kerman, Iran for the care and use of laboratory animals.
Preparation of extracts
The B. vulgaris fruits were collected from Baft dis-
trict in September 2012, Kerman province, Iran. Seeds of
N. sativa were collected from rural regions of Bam dis-
trict in September 2012, Kerman province, southeast of
Iran. The plant materials were identified by a botanist in
Botany Department, Shahid Bahonar University of
Kerman, Iran. The dried plant materials of B. vulgaris
and N. sativa (100 g) were ground and extracted by per-
colation method by ethanol and chloroform for 72 h at
room temperature, respectively. The extracts were passed
through filter paper (Whatman No. 3, Sigma, Germany)
to remove plant debris, then concentrated in vacuum at
50°C using a rotary evaporator (Heidolph, Germany) and
stored at –20°C, until testing.
Antiproliferation effects of extracts against promastigote
forms
 Antileishmanial effects of B. vulgaris and N. sativa
extracts on promastigotes were evaluated by colorimet-
ric cell viability MTT assay using the method described
by Mahmoudvand et al8. Briefly, 100 μl of the
promastigotes (106 cells/ml) harvested from logarithmic
growth phase were added into a 96-well microtiter plate.
Then 100 μl of various concentrations (0–100 μg/ml) of
each extract was added to each well and incubated at
25°C ± 1°C for 72 h. After incubation, 10 μl of MTT so-
lution (5 mg/ml) was added into each well and were incu-
bated at 25°C for 4 h. Promastigotes were cultured in com-
plete medium with no drug used as positive control, and
complete medium with no promastigotes and drugs as
blank. All the experiments were repeated thrice. Finally,
absorbance was measured by an ELISA reader (BioTek-
ELX800) at 490 nm. We also measured the 50% inhibi-
tory concentrations (IC50 value) of each extract by Probit
test in SPSS software.
Cytotoxicity of extracts in intramacrophage amastigotes
In this study, for assessment of cytotoxicity effect of
B. vulgaris and N. sativa extracts against intra-macroph-
age amastigotes of L. tropica, we used murine macroph-
ages which were collected from male BALB/c mice ac-
cording to the method described by Carrio et al16. Also
similar to promastigote stage, all the experiments were
repeated thrice. Initially, before adding the murine mac-
rophages to the plates, 1 cm2 cover slips were placed in
the wells of 6-chamber slides (Lab-Tek, Nalge Nunc In-
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ternational NY, USA). In the next step, 200 μl of the cells
(106 cells/ml) was placed in each well. After 2 h of incu-
bation at 37°C in 5% CO2 promastigotes in stationary
phase were added to murine macrophages and again in-
cubated in similar condition for 24 h. Free parasites were
removed by washing with RPMI-1640 medium and in-
fected macrophages were treated with various concentra-
tions (0–100 μg/ml) of B. vulgaris and N. sativa extracts
(50 μl) at 37°C in 5% CO2 for 72 h. At the end, dried
slides were fixed with methanol, stained by Giemsa and
studied under a light microscope. Also macrophages
containing amastigotes without extract and macrophages
with no parasite and extract were considered as positive
and negative controls, respectively. Anti-intramacrophage
amastigotes activity of extracts was assessed by the
mean infection rate (MIR) of each macrophage and
also by counting the number of intra-macrophage
amastigotes in each macrophage by examining 100 mac-
rophages (% amastigotes viability). Also the IC50 values
of each extract was calculated by Probit test in SPSS soft-
ware.
Inhibition of infection in macrophages
In order to evaluate the inhibitory effect of the B.
vulgaris and N. sativa extracts on the L. tropica incursion
of macrophages, promastigotes were pre-incubated in both
extracts (5 μg/ml), for 2 h at room temperature. Then
promastigotes were washed with RPMI-1640 medium and
incubated with murine macrophages for 4 h. After wash-
ing the cells again, the macrophages were stained by Gi-
emsa and examined by a light microscope to evaluate the
percentages of infected macrophages by counting 100
macrophages.
Cytotoxicity effect of extracts on murine macrophages
Cytotoxicity effect of the B. vulgaris and N. sativa
extracts was evaluated by cultivating macrophages
(5 × 105) with various concentrations (0–1000 μg/ml) of
both the extracts in 96-well microtiter plates, at 37°C in
5% CO2 for 72 h. Cell viability was evalutaed by colori-
metric MTT assay, and results were displayed as the per-
centage of dead cells compared to macrophages treated
with MA and non-treated macrophages (100% of viabil-
ity). In addition, the IC50 values of each extract were cal-
culated by Probit test in SPSS software.
Statistical analysis
Data analysis was carried out by using SPSS soft-
ware and ANOVA (analysis of variances) test to deter-
mine the possible significant different effects among the
extracts and control drug. Also Student’s t-test was used
to compare the IC50 values of extracts and control drug
and p <0.05 was considered as significant.
RESULTS
Antiproliferation effects of extracts against promastigotes
In the evaluation of antiproliferation effects of
ethanolic of B. vulgaris fruits and chloroform extracts of
N. sativa seeds against promastigote forms of L. tropica,
it was be observed that both the extracts significantly
(p <0.05) inhibited the growth rate of promastigotes in a
dose-dependent response compared with control drug
(Fig. 1). Similarly, the IC50 values for B. vulgaris and N.
sativa extracts against promastigotes of L. tropica were
4.83 and 7.83 μg/ml, respectively, while it was 11.26 μg/
ml for MA (Table 1).
Cytotoxicity effects of extracts against intramacrophage
amastigotes
Similar to the promastigote stage, a high cytotoxi-
city effect was demonstrated for amastigotes after 72 h
incubation. Further, results indicated that the anti-
intramacrophage amastigote effects of B. vulgaris and N.
Table 1. Comparison of the mean IC50 values among meglumine
antimoniate (MA), B. vulgaris and N. sativa against the growth
rate of promastigote and intramacrophage amastigote forms of




MA 11.2 ± 0.57 33.83  ± 1.52 436 ± 3
B. vulgaris 4.8  ± 2.08 24.03  ± 1.15 326.3 ± 2.5
N. sativa 7.3  ± 1.52 30.21 ± 1.4 447.6 ± 3.6
Data are expressed as the mean ± SD (n = 3).
Fig. 1: The viability of Leishmania tropica promastigotes in the
presence of various concentrations of the meglumine
antimoniate (MA), B. vulgaris and N. sativa after 72 h
incubation. Data are expressed as the mean ± SD (n = 3).
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sativa extracts were based on a dose-dependent manner,
so that both the extracts were compeletly able to inhibit
the growth rate of amastigote forms within macrophage
cells at different concentrations of ≥100 μg/ml (Fig. 2).
The IC50 values for B. vulgaris and N. sativa against
amastigote forms of L. tropica were 24.03 and 30.21 μg/
ml, respectively, whereas it was 33.83 μg/ml for MA
(Table 1).
Inhibition of infection in macrophages
Findings exhibited that promastigotes with no extract
of B. vulgaris or N. sativa had ability to infect 76% of the
macrophages, whereas those promastigotes treated with
the extracts of B. vulgaris or N. sativa significantly
(p <0.05) were able to infect only 18.3 or 23.6% of the
murine macrophages, respectively (Table 2).
Cytotoxicity effects of extracts on murine macrophages
Results of cytotoxicity effects of extracts on murine
macrophages by MTT assay indicated a dose-dependent
response, i.e. with increasing concentrations of both the
extracts, the cytotoxicity effect was enhanced (Fig. 3).
Also the IC50 values for B. vulgaris and N. sativa against
murine macrophages were 326.3 and 447.6 μg/ml, respec-
tively, while this value was 436 μg/ml for MA as control
drug (Table 1).
DISCUSSION
Plant-derived components and plant extracts are valu-
able sources for traditional medicines due to having less
side-effects, low cost and high availability and are mainly
used to treat a wide range of disease conditions, includ-
ing microbial infections. In the present study, we evalu-
ated antileishmanial effects of ethanolic extract of B. vul-
garis and chloroform extract of N. sativa against
promastigote and amastigote forms of L. tropica as pre-
clinical phase. Our results showed that B. vulgaris ex-
tract had potent antileishmanial activity on promastigotes
of L. tropica, and at concentration of ≥10 μg/ml totally
inhibited the promastigotes growth after 72 h of incuba-
tion. Moreover, it was able to significantly reduce the
growth and number of amastigotes in the murine mac-
rophages. Our finding also indicated that B. vulgaris ex-
tract was more effective against L. tropica promastigotes
than amastigotes since the IC50 values were higher in in-
ducing leishmanicidal effects in the amastigote-macroph-
age model. It should be mentioned that the differential
susceptibility of promastigote and amastigote stages in
response to treatment with the extracts is related to mor-
phological and biochemical features and sensitivity to the
drugs in both the parasite forms17. We have reported the
inhibitory effects of methanolic root extracts of B. vul-
garis against promastigotes of L. tropica and L. infantum
in comparison to their main component of berberine18.
Table 2. Inhibition of the infection in murine macrophages
after treatment of promastigotes of Leishmania tropica
with meglumine antimoniate (MA), B. vulgaris and N. sativa
Chemicals Percentage of Percentage of Infectiveness
infected infected reduction (%)
macrophages macrophages
by non-treated by treated
promastigotes promastigotes
MA 79.3 ± 1.52 28.3 ± 1.15 64
B. vulgaris 79.3 ± 1.52 18.3 ± 1.52 77
N. sativa 79.3 ± 1.52 23.6 ± 0.57 70
Data are expressed as the mean ± SD (n = 3).
Fig. 2: The effect of different concentrations of the meglumine
antimoniate (MA), B. vulgaris and N. sativa on the mean
number of amastigotes in each macrophage (amastigotes
viability %) in comparison with infected macrophages with
no treatment as positive control. Data are expressed as the
mean ± SD (n = 3).
Fig. 3: The cytotoxic effects of the meglumine antimoniate (MA), B.
vulgaris and N. sativa on peritoneal macrophages isolated from
Balb/c mice. Data are expressed as the mean ± SD (n = 3).
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It is important to note the distinction between fruit
and root extracts. Often, B. vulgaris is mentioned with-
out making a distinction between the fruit and the root10.
The results here show that the fruits of B. vulgaris could
inhibit both promastigotes and amastigotes of L. tropica
more efficiently than the root of the plant (IC50 of
methanolic root extract against promastigotes and
amastigotes were 16.1 and 39.4 μg/ml, respectively)19.
Considering the lack of berberine in the fruit extract of B.
vulgaris, its antileishmanial activity could be attributed
to the other components of the plant such as organic ac-
ids, especially its polyphenols. There are several studies
which indicate polyphenols potentially inhibit amastigote
and promastigote forms of different species of Leishma-
nia19–20.
So far, several studies have been carried out on anti-
microbial effects of B. vulgaris and bioactive compounds
of this plant that showed a good activity against some
microorganisms10. The study carried out by Kaneda et
al11 revealed that berberine, most important compound
of B. vulgaris, significantly suppressed the growth of
Entamoeba histolytica, Giardia lamblia and Trichomo-
nas vaginalis in BI-S-33 medium, and caused morpho-
logical changes in their structure. Furthermore, in the sur-
vey conducted by Sheng et al21 it was observed that in
chloroquine resistant malaria, a combination of berberine
and pyrimethamine showed better results in the elimina-
tion of parasites and it was more effective than other drugs
such as tetracycline or cotrimoxazole.
Vennerstrom et al12 also reported that berberine de-
rivatives significantly reduce the parasite burden in liver
or ulcer size in golden hamsters infected with L. donovani
and L. braziliensis compared with control drug
(meglumine antimoniate). The effects of B. vulgaris on
the experimental lesion of CL caused by L. major on
BALB/c mice were also investigated by some research-
ers22–23. These indicated that B. vulgaris extract signifi-
cantly reduced the size of lesion in infected mice. Re-
cently, in a study conducted by Rouhani et al24 it has
been shown that aqueous extract of B. vulgaris at the con-
centration of 4 mg/ml indicated potent scolicidal activity
against protoscoleces of hydatid cysts after 5 min incu-
bation. The present findings demonstrated that B. vulgaris
ethanolic extract is highly effective against L. tropica
probably due to the presence of bioactive compounds es-
pecially polyphenols. It should be noted that the mecha-
nism of action of polyphenols against parasites especially
Leishmania species is not clear and need to be further
explored.
N. sativa, black seed, for several decades has been
used as a natural product to treat many diseases25. In
this study, the extract of N. sativa showed potent
antileishmanial effects on promastigotes of L. tropica, so
that at concentration of ≥25 μg/ml the extract completely
eliminated the promastigote forms. Also it is capable to
significantly suppress the growth rate and number of
amastigotes in the murine macrophages. Previous study
conducted by Agrawal et al14 demonstrated antimicrobial
and antihelminthic effects of oil extract of N. sativa. Also
results of a survey conducted by Mahmoud et al15 showed
that N. sativa oil can significantly decrease the number of
Schistosoma mansoni worms and eggs in liver and intes-
tine of patients. Nilforoushzadeh et al26 indicated that
combination of honey and N. sativa extract in patients with
CL receiving glucantime is more effective to treat and
improve the clinical signs as compared to honey alone. In
contrast, in some studies, it has been proven that N. sativa
shows no significant effect on treatment of balantidiasis in
equines and Cryptosporidium parvum infection in
calves27–28. It seems that antimicrobial effects of N. sativa
extract are attribiuted to bioactive ingredients particulary
thymoquinone and other important components29.
In the present study, we demonstrated that various
extracts of B. vulgaris and N. sativa showed no significant
cytotoxicity effect on murine macrophage cells. Similar to
our findings, Peychev30 reported that the oral administra-
tion of B. vulgaris is moderately toxic in mice (LD50 =
2.6 ± 0.22 g/kg b.w. in mice). Furthermore, various stud-
ies have shown that administration of N. sativa seed ex-
tract and its components as oral or intraperitoneally repre-
sents a low level of cytotoxicity in rats and mice 31–32.
Therefore, it could be suggested that the extracts of B.
vulgaris and N. sativa are safe for mammalian cells, con-
sidering that at high concentrations exhibited significant
cytotoxicity in the host cells.
In conclusion, our findings confirmed that extracts
of B. vulgaris and N. sativa had potent antileishmanial
activity against promastiogote and amastigote stages of
L. tropica on in vitro model, whereas, these extracts ex-
hibited no significant cytotoxicity effect on murine mac-
rophage cells. Further clinical studies are required to
evaluate the exact effect of these extracts and particularly
their main components on other Leishmania species in
animal models as well as the volunteer humans as new
therapeutic agent against leishmaniasis.
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